SCHEMBL9601170

SCHEMBL9601170

Cc1ccc2ncn(COC(=O)C(C)(C)C)c(=O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.47
TNF P01375 3/20 0.46
DDR1 Q08345 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
LMNA P02545 3/20 0.43
MCL1 Q07820 1/20 0.43
ALDH1A1 P00352 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 2/20 0.41
THRB P10828 1/20 0.40
POLB P06746 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5565180 0.88 TNF (0.43) TNFSMN1; SMN2LMNAMCL1ALDH1A1
SCHEMBL9252072 0.85 TNF (0.43) TRPA1TNFSMN1; SMN2LMNAMCL1
SCHEMBL9253194 0.85 LMNA (0.43) TRPA1TNFSMN1; SMN2LMNAMCL1
SCHEMBL6589975 0.84 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9AMAPTLMNA
SCHEMBL13646422 0.82 TNF (0.56) TNFSMN1; SMN2MAPTLMNAMCL1
SCHEMBL12388859 0.81 TNF (0.42) TNFSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL5500566 0.81 ESR1 (0.47) TNFSMN1; SMN2MAPTLMNAALDH1A1
SCHEMBL9245910 0.78 POLB (0.45) SMN1; SMN2NPC1MAPTLMNAALDH1A1
SCHEMBL666304 0.78 HDAC6 (0.54) TNFMAPTALDH1A1MEN1KMT2A
SCHEMBL9366964 0.77 MMP13 (0.52) SMN1; SMN2THRBPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5236927-A Reduced toxicity; side effect reduction NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1993-08-17 US disclosed
EP-0204529-B1 ANTI-CANCER QUINAZOLINE DERIVATIVES BTG INTERNATIONAL LIMITED (GB) 1993-03-31 EP disclosed
EP-0204529-A2 Anti-cancer quinazoline derivatives BTG INTERNATIONAL LIMITED (GB) 1986-12-10 EP disclosed